Clinical Research > Global Study Management
With its own bases in Japan and the US, Iberica is able to provide an in-house solution for two of the ICH regions, and by leveraging its strategic partnership with TFS Trial Form Support International AB (TFS), Iberica Holdings is able to offer a global study solution that incorporates all ICH regions.
Also by leveraging the clinical pharmacology units both in Japan and US, Iberica provides unique services such as global PK/PD studies, simultaneous PK/PD studies in Japanese and US nationals within the US, meeting Sponsor’s needs for global studies in the early clinical development and Sponsor’s particular development strategies.